Owlet Forecasts Q4 Loss of $0.13 With 24.1% Revenue Growth, Expands Partnerships
Owlet is set to report fiscal Q4 with a projected EPS loss of $0.13 (down 85.7% year-over-year) on revenues of $25.43 million, marking 24.1% growth. The company also inked strategic DME distribution partnership with PromptCare for its BabySat oximeter and an AI collaboration with webAI for personalized infant health insights.
1. Upcoming Fiscal Q4 Outlook
Owlet is projected to post a loss of $0.13 per share for fiscal Q4, representing an 85.7% decline year-over-year, on revenues of $25.43 million, up 24.1% from the prior year. This guidance sets expectations for the company’s upcoming earnings release and will influence investor sentiment on profitability and growth trajectory.
2. Distribution Partnership with PromptCare
The company secured a strategic DME distribution agreement with PromptCare to broaden the reach of its BabySat pediatric pulse oximeter. This partnership aims to accelerate adoption in home healthcare and outpatient settings by leveraging PromptCare’s established medical equipment network.
3. AI Collaboration with webAI
Owlet entered an AI partnership with webAI to develop personalized infant health and sleep insights using advanced analytics. This collaboration is intended to enhance the company’s software platform, driving engagement and positioning Owlet to monetize data-driven subscription services.